Vantage logo

Ash 2021 roundup

Evaluate Vantage's coverage of the Ash 2021 congress.

Vantage logo

Bluebird split looks premature

Today’s safety scare with Lentiglobin calls into question the logic behind Bluebird’s planned business separation.

Vantage logo

Finding the next Prevail

An $880m buyout by Lilly shows that some gene therapy companies have not yet priced themselves out of the market.